BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21115928)

  • 1. Prognostic value of cytogenetic analysis in clear cell renal carcinoma: a study on 131 patients with long-term follow-up.
    Antonelli A; Arrighi N; Tardanico R; Balzarini P; Zanotelli T; Corti S; Zani D; Cozzoli A; Cunico SC; Simeone C
    Anticancer Res; 2010 Nov; 30(11):4705-9. PubMed ID: 21115928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis.
    Gunawan B; Huber W; Holtrup M; von Heydebreck A; Efferth T; Poustka A; Ringert RH; Jakse G; Füzesi L
    Cancer Res; 2001 Nov; 61(21):7731-8. PubMed ID: 11691785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic features, clinical significance and prognostic impact of type 1 and type 2 papillary renal cell carcinoma.
    Antonelli A; Tardanico R; Balzarini P; Arrighi N; Perucchini L; Zanotelli T; Cozzoli A; Zani D; Cunico SC; Simeone C
    Cancer Genet Cytogenet; 2010 Jun; 199(2):128-33. PubMed ID: 20471516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
    Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas.
    Kardas I; Mrózek K; Babinska M; Krajka K; Hadaczek P; Lubinski J; Roszkiewicz A; Kuziemska E; Limon J
    Oncol Rep; 2005 May; 13(5):949-56. PubMed ID: 15809763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical treatment of perplexing renal cell carcinoma].
    Lin Z; Chen S; Ye C
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):463-4. PubMed ID: 10920947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of quantitative chromosomal abnormalities in renal cell carcinomas by interphase four-color fluorescence in situ hybridization.
    Receveur AO; Couturier J; Molinié V; Vieillefond A; Desangles F; Guillaud-Bataille M; Danglot G; Coullin P; Bernheim A
    Cancer Genet Cytogenet; 2005 Apr; 158(2):110-8. PubMed ID: 15796957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cyto- and molecular genetic studies of renal cell carcinoma with special reference to multifocal carcinoma lesions].
    Schlichter A; Junker K; Kosmehl H; Katenkamp D; Claussen U; Schubert J
    Urologe A; 1996 Jul; 35(4):305-9. PubMed ID: 8928359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of microscopic venous invasion in renal cell carcinoma: long-term follow-up.
    Lang H; Lindner V; Letourneux H; Martin M; Saussine C; Jacqmin D
    Eur Urol; 2004 Sep; 46(3):331-5. PubMed ID: 15306103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
    Dall'Oglio MF; Arap MA; Antunes AA; Cury J; Leite KR; Srougi M
    J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of vitamin D receptor and retinoid X receptor expression in renal cell carcinoma.
    Obara W; Konda R; Akasaka S; Nakamura S; Sugawara A; Fujioka T
    J Urol; 2007 Oct; 178(4 Pt 1):1497-503. PubMed ID: 17707062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytogenetic analysis of 19 renal cell tumors].
    Cerasoli S; Spada F; Buda R; Turci A; Giangaspero F
    Pathologica; 2001 Apr; 93(2):118-23. PubMed ID: 11428288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological, immunohistochemical and cytogenetic features of papillary renal cell carcinoma with clear cell features.
    Klatte T; Said JW; Seligson DB; Rao PN; de Martino M; Shuch B; Zomorodian N; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Urol; 2011 Jan; 185(1):30-5. PubMed ID: 21074210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Traditional and future criteria for progression in renal cell carcinoma. Molecular biology and clinical aspects].
    Pomer S; Staehler G
    Urologe A; 1996 May; 35(3):254-62. PubMed ID: 8711834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression in kidney cancer is associated with cytogenetic abnormalities, metastasis formation, and patient survival.
    Sültmann H; von Heydebreck A; Huber W; Kuner R; Buness A; Vogt M; Gunawan B; Vingron M; Füzesí L; Poustka A
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):646-55. PubMed ID: 15701852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Swanson DA; Wood CG
    Cancer; 2008 Apr; 112(7):1480-8. PubMed ID: 18240184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous p27(Kip1) expression within primary renal cell cancers, their invasive margins and peritumoral renal parenchyma correlation with pathological and prognostic features.
    Merseburger AS; Serth J; von der Heyde E; Kobierski A; Wegener U; Mengel M; Jonas U; Kuczyk M
    Urol Int; 2007; 79(2):164-9. PubMed ID: 17851288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.